Antigen-specific CD8+ T cells induced by the ubiquitin fusion degradation pathway

Biochemical and Biophysical Research Communications

Volumn 365, Issue 4, 2008, Pages 758-763

  Imai, Takashi ^a   Duan, Xuefeng ^a   Hisaeda, Hajime ^a   Himeno, Kunisuke ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

CD8+ T cells; DNA vaccine; Ubiquitin; Ubiquitin fusion degradation pathway

Indexed keywords

GLYCINE; OVALBUMIN; UBIQUITIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CD8+ T LYMPHOCYTE; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; ANTIGENS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; MICE; RECOMBINANT FUSION PROTEINS; UBIQUITIN;

EID: 37049038177     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.11.034     Document Type: Article

References (15)

1. Kloetzel P.M. The proteasome and MHC class I antigen processing. Biochim. Biophys. Acta 169 (2004) 5225-5233
2. Strehl B., Seifert U., Krüger E., Heink S., Kuckelkorn U., and Kloetzel P.M. Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing. Immunol. Rev. 207 (2005) 19-30
3. Schwartz A.L., and Ciechanover A. The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu. Rev. Med. 50 (1999) 57-74
4. Wilkinson K.D. Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. Semin. Cell Dev. Biol. 11 (2000) 141-148
5. Chung C.H., and Baek S.H. Deubiquitinating enzymes: their diversity and emerging roles. Biochem. Biophys. Res. Commun. 266 (1999) 633-640
6. Johnson E.S., Bartel B., Seufert W., and Varshavsky A. Ubiquitin as a degradation signal. EMBO J. 11 (1992) 497-505
7. Johnson E.S., Ma P.C., Ota I.M., and Varshavsky A. A proteolytic pathway that recognizes ubiquitin as a degradation signal. J. Biol. Chem. 270 (1995) 17442-17456
8. Butt T.R., Khan M.I., Marsh J., Ecker D.J., and Crooke S.T. Ubiquitin metallothionein fusion protein expression in yeast, A genetic approach for analysis of ubiquitin functions. J. Biol. Chem. 263 (1998) 16364-16371
9. Ecker D.J., Stadel J.M., Butt T.R., Marsh J.A., Monia B.P., Powers D.A., Gorman J.A., Clark P.E., Warren F., Shatzman A., and Crooke S.T. Increasing gene expression in yeast by fusion to ubiquitin. J. Biol. Chem. 264 (1989) 7715-7719
10. Duan X., Hisaeda H., Shen J., Tu L., Imai T., Chou B., Murata S., Chiba T., Tanaka K., Fehling H.J., Koga T., Sueishi K., and Himeno K. The ubiquitin-proteasome system plays essential roles in presenting an 8-mer CTL epitope expressed in APC to corresponding CD8+ T cells. Int. Immunol. 18 (2006) 679-687
11. Ishii K., Hisaeda H., Duan X., Imai T., Sakai T., Fehling H.J., Murata S., Chiba T., Tanaka K., Hamano S., Sano M., Yano A., and Himeno K. The involvement of immunoproteasomes in induction of MHC class I-restricted immunity targeting Toxoplasma SAG1. Microbes Infect. 8 (2006) 1045-1053
12. Barry M.A., Lai W.C., and Johnston S.A. Protection against mycoplasma infection using expression-library immunization. Nature 377 (1995) 632-635
13. Teramoto K., Kontani K., Ozaki Y., Sawai S., Tezuka N., Nagata T., Fujino S., Itoh Y., Taguchi O., Koide Y., Asai T., Ohkubo I., and Ogasawara K. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy. Cancer Res. 15 (2003) 7920-7925
14. Deng H., Kowalczyk D., O I., Blaszczyk-Thurin M., Quan Xiang Z., Giles-Davis W., and Ertl H.C. A modified DNA vaccine to p53 induces protective immunity to challenge with a chemically induced sarcoma cell line. Cell Immunol. 215 (2002) 20-31
15. Vidalin O., Tanaka E., Spengler U., Trepo C., and Inchauspe G. Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination. DNA Cell Biol. 8 (1999) 611-621